Get Newsletter
Alzheimer Research Forum - Networking for a Cure Alzheimer Research Forum - Networking for a CureAlzheimer Research Forum - Networking for a Cure
  
What's New HomeContact UsHow to CiteGet NewsletterBecome a MemberLogin          
Papers of the Week
Current Papers
ARF Recommends
Milestone Papers
Search All Papers
Search Comments
News
Research News
Drug News
Conference News
Research
AD Hypotheses
  AlzSWAN
  Current Hypotheses
  Hypothesis Factory
Forums
  Live Discussions
  Virtual Conferences
  Interviews
Enabling Technologies
  Workshops
  Research Tools
Compendia
  AlzGene
  AlzRisk
  Antibodies
  Biomarkers
  Mutations
  Protocols
  Research Models
  Video Gallery
Resources
  Bulletin Boards
  Conference Calendar
  Grants
  Jobs
Early-Onset Familial AD
Overview
Diagnosis/Genetics
Research
News
Profiles
Clinics
Drug Development
Companies
Tutorial
Drugs in Clinical Trials
Disease Management
About Alzheimer's
  FAQs
Diagnosis
  Clinical Guidelines
  Tests
  Brain Banks
Treatment
  Drugs and Therapies
Caregiving
  Patient Care
  Support Directory
  AD Experiences
Community
Member Directory
Researcher Profiles
Institutes and Labs
About the Site
Mission
ARF Team
ARF Awards
Advisory Board
Sponsors
Partnerships
Fan Mail
Support Us
Return to Top
Home: News
News
News Search  
Aβ Production Linked to Oxidative Stress
7 June 2004. Oxidative stress has been postulated as a major factor in the pathology of a variety of neurodegenerative disorders, including Alzheimer’s disease (AD). However, evidence linking this type of stress to the major hallmark of AD, amyloid plaques, has been less than direct. Now, in this month’s Journal of Neurochemistry, Gunnar Gouras and colleagues at Cornell University, New York, show that knocking out superoxide dismutase in mice leads to accelerated accumulation of plaques.

Superoxide dismutase (SOD) is a major scavenger of the highly reactive oxygen species that are generated in mitochondria. Gouras and colleagues wondered how loss of the mitochondrial variant of the enzyme, which harbors a manganese atom at its catalytic core, would affect the accumulation of amyloidβ plaques in mice. To test this, first author Feng Li and colleagues crossed mice that are missing one copy of the MnSOD with mice that express human amyloid-β precursor protein (AβPP) that harbor mutations causing early-onset AD. These animals, or APP19959 mice as they are called, begin to accumulate amyloid plaques as early as three months old.

When Li examined the offspring, they found that those with only one copy of the MnSOD had protein markers of oxidative stress that were almost twice as high as in animals carrying two good copies of the dismutase. The authors also found that by four months old, Aβ was elevated by about 25 percent in brains of the MnSOD knockouts. These animals also had considerably increased plaque burden. When the authors measured plaques by immunohistochemistry, they found a ninefold increase in hippocampal, and an eightfold increase in cortical plaques. “To our knowledge,” write the authors, “our results are the first to show in vivo that a primary perturbation of free radical metabolism causes exacerbation of the amyloid pathology characteristic of AD.”

Recently, the association between oxidative stress and neurodegeneration has been strengthened by a variety of studies. Mutations that cause Parkinson’s disease, for example, have been linked to proteins that function in mitochondria, the major site for production of reactive oxygen species (see ARF related news story, and ARF related story). Connections to AD include studies that suggest a mitochondrial complex between Aβ and alcohol dehydrogenase promotes leakage of reactive oxygen species and cell death (see ARF related news story), and the identification of a carbonyl reductase, which is elevated in AD and which can protect against oxidative stress-induced neurodegeneration (see ARF related news story). All told, it seems that our mitochondria, the powerhouses that keep us going, may also be somewhat of an Achilles' heel for our aging brains.—Tom Fagan.

Reference:
Li F, Calingasan NY, Yu F, Mauck WM, Toidze M, Almeida CG, Takahashi RH, Carlson GA, Beal MF, Lin MT, Gouras GK. Increased plaque burden in brains of APP mutant MnSOD heterozygous knockout mice. J. Neurochem. 2004;89:1308-1312. Abstract

 
  Submit a Comment on this News Article
Cast your vote and/or make a comment on this news article. 

If you already are a member, please login.
Not sure if you are a member? Search our member database.

*First Name  
*Last Name  
Country or Territory:
*Login Email Address  
*Password    Minimum of 8 characters
*Confirm Password  
Stay signed in?  

I recommend the Primary Papers

Comment:

(If coauthors exist for this comment, please enter their names and email addresses at the end of the comment.)

References:


*Enter the verification code you see in the picture below:


This helps Alzforum prevent automated registrations.

Terms and Conditions of Use:Printable Version

By clicking on the 'I accept' below, you are agreeing to the Terms and Conditions of Use above.
Print this page
Email this page
Alzforum News
Papers of the Week
Text size
Share & Bookmark
ADNI Related Links
ADNI Data at LONI
ADNI Information
DIAN
Foundation for the NIH
AddNeuroMed
neuGRID
Desperately

Antibodies
Cell Lines
Collaborators
Papers
Research Participants
Copyright © 1996-2013 Alzheimer Research Forum Terms of Use How to Cite Privacy Policy Disclaimer Disclosure Copyright
wma logoadadad